5 6 7 8 9 10 10 12 16 20 22 23 24 32 36 39 45 49 50 51 52 56 58 59 60 62 64 65

5 6 7 8 9 10 10 12 16 20 22 23 24 32 36 39 45 49 50 51 52 56 58 59 60 62 64 65 72 75 77 80 82 84 97 100 106 107 111 114 117 118 121 125 127 130 130 131 132 133 133 135 135 136 136 137 138 138 140 141 142

untitled

2

2

60 17 3 60 8 1 4 JR 4 6 2 2

⑴ ⑵ ⑶

2

MRI..06-8...X......

.g.i.~.^.A..........

ヴィエトナム高原におけるマッシュルーム栽培の基本

2.

2. 10 2. 2. 1995/12006/111995/42006/12 2. 10 1995120061119954200612 02505 025 05 025 02505 0303 02505 250100 250 200 100200 5010050 100200 100 100 50100 100200 50100 10 75100100 0250512 02505 1 025051205

281

m3 m3 m3 280 281 m3 m3 282 283 ⑴ ⑵ m3 m3 m3 m3 m3 m3 m3 m3 m3 m3 284 ⑵ m3 m3 m3 m3 m3 m3 m3 m3 m3 m3 ⑶ ⑷ 285 ⑴ 286 ⑵ ⑶ 287 (1) 92.3 288 289 (2) 40,700 () () () () () () () () () () () ( ) () () () () (ha)

2 1 2 3 27 2 6 2 5 19 50 1 2

1 2 1 2 3 27 2 6 2 5 19 50 1 2 2 17 1 5 6 5 6 3 5 5 20 5 5 5 4 1 5 18 18 6 6 7 8 TA 1 2 9 36 36 19 36 1 2 3 4 9 5 10 10 11 2 27 12 17 13 6 30 16 15 14 15 16 17 18 19 28 34 20 50 50 5 6 3 21 40 1 22 23

01

2 ( 178 9)

( 1,876.58 km2) 98 ( 11 ) ( 21 ) 4 17 (8 9 ) 28 6 1? H25.12 11,998 489.5 H26.12 13,392 111.6% 565.5 115.5% H27.12 13,828 103.3% 476.8 84.3% H25.12 84 4.5 H26.12 132 157.1% 5 111.1% H27.12 95 72.0 2.56

⑴ ⑵ ⑶ ⑷ A C B ( D Other A C B ( D 1996/2/1 1996/3/1 1996/6/1 1996/8/1 1996/9/1 1997/3/1 1997/5/1 1997/6/1 1997/6/1 1997/6/1 1997/10/1 1997/10/1 1997/10/1 1997/11/1 1997/11/1

-2 -

-1 - -2 - ⑴ ⑵ -3 - ⑶ -4 - ⑴ ⑵ ⑶ -5 - ⑷ 6,268 16 23,256,247.299 39.48 8,385. 34 35 2 2,117. 34 4 3,936 8 16,544,761.1 28.8 5,625. 927 35 14 1,689. 927 6 872 6 7,765,329.122 13.18 3,83. 554 17 7 2,211. 554

0 001212 112468 1 10 2 11 12 13 3 14 15 ⑴ ⑵ ⑴ ⑵ ⑴ ⑵ ⑴ 4 ⑵ 5 6 ⑴ ⑴ ⑴ ⑵ 7 ⑶ ⑷ ⑵ ⑴ 8 ⑵ ⑴ 9 ⑴ ⑵ ⑴ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑴ ⑵ ⑵ 10 11 ⑷ ⑴ ⑵ ⑶ ⑵ ⑷ ⑸ ⑴ ⑴ ⑵ ⑴ ⑵ ⑶ 12 ⑵ ⑵ ⑴ ⑵ ⑶ ⑴ ⑵ 13 ⑶ ⑴ ⑵ ⑴ ⑵ ⑴ 14 ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑴ ⑵ ⑵ 15

( ) M5, 2007 67.3 67.3 N=97 34.9 34.9 N=97 PBL- PBL- () PBL- PBL- 48.1 48.1 N=97 86.9 86.9 N=97 36.2 36.2 N=97 55.6 55.6 N=97 M5, 2007 N=101 CBT r 0.146 PBL- 4%2% 7% 5% 2% 5% 9% 66% N=82 : 1020 : 301 :

⑴ ⑵ ⑶

- 108 - ⑴ ⑵ ⑶ ⑴ ⑵ ⑶ ⑷ - 110 - ⑴ ⑵ ⑶ - 111 - ⑷ ⑴ ⑸ ⑹ ⑵ ⑶ - 112 - ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ - 115 - - 116 - - 117 - - 118 - - 119 - - 120 - ⑴ - ⑴ ⑴ ⑵ ⑴ ⑵ ⑵ ⑴ ⑵ ⑴ ⑵ - 122 - - 123 - ⑴ ⑵ ⑴ ⑵ ⑶ - 124 - ⑷ - 125 -

⑴ ⑵ ⑶

- 108 - ⑴ ⑵ ⑶ ⑴ ⑶ ⑵ ⑷ ⑴ ⑵ - 110 - ⑶ - 111 - ⑷ ⑴ ⑸ ⑹ ⑵ ⑶ - 112 - ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ - 115 - - 116 - - 117 - - 118 - ⑴ - 119 - - 120 - ⑴ ⑴ ⑵ ⑴ ⑵ ⑵ - 121 - ⑴ ⑵ ⑴ ⑵ - 122 - - 123 - ⑴ ⑵ ⑴ ⑵ - 124 - ⑶ - 125

⑴ ⑵ ⑶

⑴ ⑵ ⑶

⑴ ⑵ ⑶

123 ( 17 120 18 ) ( - 1 - - 2 - ⑴ ⑵ - 3 - - 4 - ⑴ - 5 - ⑵ - 6 - ⑶ - 7 - ⑴ ⑵ ⑶ - 8 - - 9 - - 10 - - 11 - ⑴ ⑵ ⑶ - 12 - ⑴ - 13 - ⑵ 12-14 - - 15 - - 16 - - 17 - - 18 - ⑴ ⑵ - 19 - ⑴ ⑵ ⑶ - 20 - ⑷ ⑸ ⑹ - 21 -

⑴ ⑵ ⑶ ⑷ 1

⑵ ⑶ ⑷ ⑸ ⑴ ⑵

第79回_プログラム.indd

Regulation of ghrelin signaling by a leptin-induced gene, negative regulatory element-binding protein, in the hypothalamic neurons. Phase I clinical trial using peptide vaccine for human vascular endothelial

⑷

⑶

2

○01　那覇市（７月変更）

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 H26,2 H28.2 9 9 38 39 40 41 42 43 l ll 44 45 46 47 48 49 50 51 52 53 54 55 2733 14,500 56 57 58 59

日本糖尿病学会誌第58巻第1号

α β β β β β β α α β α β α l l α l μ l β l α β β Wfs1 β β l l l l μ l l μ μ l μ l Δ l μ μ l μ l l ll l l l l l l l l μ l l l l μ μ l l l l μ l l l l l l l l l l μ l l l μ l μ l l l l l l l l l μ l l l l

untitled

9 8 29 () 9 8 29 () 9 11 30 () 10 2 14 () 3 10 7 24 () 10 10 9 () 10 8 2 10 11 14 () 10 12 25 () 40 50 100 1953 11 2 26 11 11 3 29 11 6 10 11 1 12 15 2 3 12 12 10 6 12 4 8 5 55 60 100 100 2 25 15 7 29

プリント

l l l l ll l l l l l l l l l l l 𩸽 l l l l l ll l l l l l l l l l ll l l l l l l l l ll ll l l l l l l ll ll ll l

<313430378BB388E79770837283668349835C837483672E696E6464>

Microsoft Word 年度.docx

3. (,) 1(,,) () 2. () 1 FD () (,,,,,) 19. () 20. () 21. () 23 24 25International Society for Stem Cell Research(ISSCR) - 1. Sumita Y, Liu Y, Khalili S, Maria OM, Xia D, Key S, Cotrim AP, Mezey E, Tran

第40巻第１号【論説】ホンダのデザイン戦略

40 1 2001 5 31 2 1 1) 2) 5 6 TQM 2 2 1) 2 2) M M 3 RV 1) RV 2) 1BOX 1970 4 ( ) 1980 2 1990 73 83 2 1999 6 16 32 40 1 95 4 1) 3 2 1. 1) 10 3 10 3 N 360 H1300 1972 1) 39 6 2001 53 66 33 T 1908 20 T 2) T

01_杵渕.indd

1 直 線 的 キャリア 論 の 限 界 日 本 人 の 身 体 観 から 杵 渕 友 子 19571992 19751977 2 16 1990 1949 3 1994 4 10 11 12 13 14 15 16 17 300 18 5 201319 19 20 21 22 23 24 6 25 26 1648 19 7 27 28 29 8 30 31 9 32 33 105 10 34 35

RA宣言.PDF

untitled

02

54 163116831 02 1 168 54 158 53 162 53 148 52 152 52 10,000 0 40,000 30,000 20,000 50,000 70,000 60,000 1,000 500 1,500 2,000 0 2,500 3,000 4,000 3,500 4,500 168 54 158 53 162 53 148 52 152 52 03 52148

Microsoft Word - 2TXL実施要綱 doc

みつめて_あなたを.indd

2

C/NC : committed/noncommitted

C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

日本消化器外科学会雑誌第29巻第9号

Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

1891 DVD 1

第６１巻５・６号（１２月号）／特集１頁目（本刷）

Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture

P099～148（04宮部真由美）.PDF

Microsoft Word - 19 ‚¾Šz”©fi®”Ô.doc

01 Total assist Total assist 02

01 Total assist Total assist 02 03 Total assist Total assist 04 05 Total assist Total assist 06 07 Total assist Total assist 08 09 Total assist Total assist 10 11 Total assist Total assist 12 0120-650-350

.Z.................\111...R.s.[

floor Q & A CONTENTS Q1 Q & A 2 Q.1 Q2 Q3 2 2 A.1 Q4 3 Q5 3 Q6 3 4 4 Q.2 Q.7 Q.8 5 6 6 6 A.2 7 9 9 Q.3 A.3 1 2 Q & A Q.4 A.4 Q.5 A.5 Q.6 A.6 3 4 5 6 7 8 9 10 2 3 4 5 7 7 7 8 9 9 10 10 11 12 13 14 14 P.3

1 1 1 1 28 9 1 13 30 15 30 2 28 9 6 10 00 12 00 3 28 9 6 14 00 16 00 4 28 9 7 10 00 12 00 2 2 5 8 6 9 1 5 28 9 7 14 00 16 00 7 6 28 9 9 13 30 15 30 2 5 9 10 11 12 1 2 3 16 7 13 28 15 19 21 119 28 5 10

平成２２年度

( 2 4 9 (4 11 ) H26.3 5 6 + 7 8 25 24 1 1 184 22 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 24 10 9 29 24 12 27 23 1 11 6 4 6 9 3 1 1 1 2

日本化学療法学会雑誌第56巻第1号

β β β β β Streptococcus pneumoniaehaemophilus influenzaemoraxella catarrhalismycoplasma pneumoniaechlamydia pneumoniae β Key wordsβ mys nilc laci ngis Table. Assessmentschedule Parameters Patientcharacteristics

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients with acute congestive heart failure Jung-Myung Lee,

H O S H I G E N E R

Microsoft Word - 02_21　衛星通信車調達仕様書

366 12 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 1 8 DNA 2,3 16 12 20 171 2008 12 2010 11 2 3,558 4.44% 1.65% 1.17% 90% 9 Escherichia coli -

Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 365 11 sita oxacin 1 1 1 1 1 1 2 2 3 3 1 1 1 2 3 2012 9 14 sita oxacin STFX 50 mg 10% 2008 1 2008 12 2010 11 2 STFX 1,452 91.4% 1,235/1,351 95.9% 466/486

スライド 1

1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00

Coronary spasm associated myocardial infarction without organic stenosis at acute stage Yoshiaki Mikuriya*, Yoichi Tatsukawa*, Fumie Yufu*, Hirofumi Zaizen*, Katsuhiro Wakayama*, Yuuki Matsumoto*, Shoji

untitled

27 DVD P2 P10 P3 P10 P3 P1113 P310 P14-1 - 27 DVDDVD DVD DVD - 2 - 27-3 - 27-4 - 27-5 - 27-6 - 27-7 - 27-8 - 27-9 - 27 6/25 7/9 7/198/2 7/318/4 8/14 8/21 8/27 9/11 9/1719-10 - 27-11 - 27-12 - 27-13 - 27-14

1

1 ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑸ ⑹ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑸ ⑴ ⑵ ⑶ ⑷ ⑸ 21 700 21-1 - 2006 18 2015 27 10-2 - ⑴ WTO 2002 14 1 7 1500 7 2010 10 2020 16 11.4% 21 2010 1000 21 2003 15 7 VJC ⑵ 17 2004 16 2.00 5%

kl l ml l l l ml ml ml ml ml ml ml ⑴ ⑴ ⑴ ⑴ ⑴ l l l l ⑵ ⑵ ⑵ l l ⑶ l ⑶ l ⑵ l ⑵ ⑶ l ⑷ l l l l ⑶ ⑶ l l l l ⑷ ⑷ l l l ml ml ml ml ml ml ml ml ml ml ml ml ml ml ml ⒈ ⒉ ⒊ ⒋ ⒈ ⒉ ⒊ ⒋ ⒈ ⒉ ⑴ ⑵ ⒊ ⒋ ⒈ ⒉ ⒊

Microsoft Word - 1表紙

26 -15 - -5 5 15 2-22 78-125 -85 19-25 -22 54 34 12 193 182 195-19 68 ⑴ ⑵ ⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑶ ⑷ ⑸ ⑴ 2 3 4 5 6 7 17.8 31.7.2 2.9 23.4 3.8 49.7 63.6 8.3 6.1 7.3 14.2 4.5 15.5 7.4 6.6 15.4 13.9 7.7

HIV/AIDS HIV/AIDS 1 5

Vol.32 Aug.2004 http://hc3.seikyou.ne.jp/home/a-w-f/ E-mail: a-w-f@mc3.seikyou.ne.jp TEL/FAX 092-715-4119 815-8619 38 HIV/AIDS HIV/AIDS 1 5 HIV/AIDS 1 HIV/AIDS HIV/AIDS, 28 100 HIV/AIDS HIV/AIDS HIV/AIDS

吹田市告示第　　号

⑴ ⑵ ⑶ ⑷ ⑴ ⑵ ⑴ 総 評 ⑵ 施 策 の 評 価

H28.4 / 11 28 7 1 28 28 1 27 29 30 4 1 29 5 5 2 2 1 2 2 28 3 1 28 http://www.city.saitama.jp/005/001/018/003/p036471.html 2 28 7 11 28 8 31 3 CD DVD 4 4 5 7 11 8 31 9 1 9 30 10 1 10 31 11 1 11

2014国際h1_h4

第５７巻２号／投稿規定・目次・表２・奥付・背

Feature articlesdiet in a society with a growing elderly population and a low birth rate Original The problems of breastfeeding Kazuhisa Maeda, Ryuji Mitani, Satoko Endo, Yoshika Saijo, and Toshihiro

「東京都子供・子育て支援総合計画」中間見直し版（案）第2章　子供と家庭をめぐる状況

1 (1) (2) (3) (4) (5) (6) (7) (8) 2 (1) (2) (3) (4) (5) (6) (7) 10,000 100% 8,000 78.7% 78.1% 79.3% 78.3% 74.1% 75.4% 73.2% 80% 6,000 46.6% 47.5% 50.9% 51.5% 49.9% 51.8% 52.2% 60% 4,000 2,000 3,713

?!!!!

一般社団法人 日本感染症学会 第89回総会資料

Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000 2011 Journal of Infection and Chemotherapy Vol.19No.1 p34-41kimiko Ubukata Long-term

屋外広告物のしおり

2 1 ⑴ 2 ⑵ 3 ⑴ ⑵ 4 5 ⑴ ⑵ 6 ⑶ 7 ⑴ ⑵ ⑶ 8 ⑷ ⑸ ⑴ ⑵ 9 10 11 ⑴ ⑵ 12 13 14 15 16 17 ⑶ 18 ⑴ ⑵ ⑶ 19 20 21 22 23 24 25 26 27 ⑴ 10 ⑵ ⑴ 28 ⑶ ⑴ ⑴ ⑴ ⑵ 29 ⑶ ⑷ ⑸ 30 ⑹ ⑺ ⑻ ⑼ ⑽ ⑾ 31 ⑴ ⑵ ⑶ ⑷ 32 ⑴ ⑵ 33 34 35 36 37 38 39 40

6574 75 60,000 50,000 40,000 30,000 20,000 10,000 28,351 28,998 29,682 30,506 30,099 27.4 26.5 25.8 25.9 25.5 24,525 24,422 23,595 23,952 24,894 30.0 29.0 28.0 27.0 26.0 25.0 24.0 0 21 22 23 24 25 23.0

...A

⑴ ⑵ ⑶ ⑵

untitled

24 242012 4 1 6 11 1 11 2 21 3 45 4 69 79 1 2 Kindness of Heart Intellectual Curiosity Team Spirit Integrity Diligence Energy Autonomy Leadership Self-Realization 3 4 5 21 KIT 1 32 6 1 33 4 1 34 4 1 37

untitled

72 22 30 1985 Conductance Vessels flow Vessels< - Shear stress conductance vessel Exercise and Adenosine SPECT in the Patient with Angina SPECT,PET ACC/AHA/ASNC Guideline 2003 Dicarli JNM 2007;48:783

計算機生命科学の基礎II_

Ⅱ 1.4 atsushi_doi@cell-innovator.com 812-8582 3-1-1 8 806 http://www.cell-innovator.com BioGPS Connectivity Map The Cancer Genome Atlas (TCGA); cbioportal GO DAVID, GSEA WCGNA BioGPS http://biogps.org/

精神障害者ホームヘルプサービスにおける教育の充実化

1987 62 1993 1999 11 2002 14 1999 11 2002 14 12 7 2 1 disease impairment disability handicap WHO 1980 1999 11 1,530 4,020 2002 14 1995 1998 2 10 2000 12 2003 15 1991 1994 51 1997 1998 10 3,261 ⑴ 3 p.82

VOL. 21 NO. 2 CHEMOTHERAPY 395

394 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 395 396 CHEMOTHERAPY MAR. 1973 VOL. 21 NO. 2 CHEMOTHERAPY 397 398 CHEMOTHERAPY MAR. 1973 VOL. 2 1 NO. 2 CHEMOTHERAPY 399 400 CHEMOTHERAPY MAR. 1973

奈良県立医科大学耳鼻咽喉・頭頸部外科学-2016年Facebookページ記事.pages

2016 1 10 ( ) 1:22 UTC+09 52 2016 1 10 ( ) 1:30 UTC+09 70 2016 1 10 ( ) 10:15 UTC+09 2016 1 10 ( ) 13:29 UTC+09 70 Lucky Cat 2016 1 15 ( ) 18:54 UTC+09 2 ( 5 ) 5 ( 6 ) 7 2016 1 29 ( ) 17:55 UTC+09 2 (

science

science IT PERSON TO PERSON EU IT IT WHO TV I T Harvard University Brigham and Women s Hospital, Renal Division UCSF CT MRI IT 1 40 17 3 27 Winslow 1949 Impact Factor 50 1 16 1 NIH Samuel W. Cushman

untitled

260 250 200 150 10 100 50 0 1960 1965 1970 1975 1980 1985 1985 1995 2000 2005 25% 56% 66% 60% 90 80 70 60 50 40 30 20 10 0 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 4 1999 1990 2003 2005 2010 500,000 70,000 100,000

⑴ ⑵ ⑶ ⑷ ⑸ ⑹ ⑺ ⑻ ⑼ ⑽ ⑴ ⑵ ⑶ ⑷ ⑸ ⑹ ⑺ ⑻ ⑼ ⑽ ⑾ ⑿ ⒀ ⒁ ⒂ ( ), (53.1%) (61.8%) (30.9%) 84.1% 95.7% 13.7% 11.3% 3.3% 4.7% 4.0% 74.6% 6.7 ( ) 64.5% 752 57.1% 565 42.9% 1317 100.0% 90.3% 47.4%52.6% 63.4%36.6%

Feb THE JAPANESE JOURNAL OF ANTIBIOTICS Tebipenem pivoxil 1 1, Meiji Seika 2 Meiji Seika G 3 Meiji Seika Tebipen

Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 53 53 Tebipenem pivoxil 1 1, 3 2 2 1 1 Meiji Seika 2 Meiji Seika G 3 Meiji Seika 2015 12 15 Tebipenem pivoxil 10% 2010 4 2013 3 3,547 3,540 3,540 3,331